Sarah Shaw
Optometrist · Warsaw, NYNPI 1720492440
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 28.7% of the total.
Across 51 payments — averaging $23.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$338
- Tarsus Pharmaceuticals, Inc.$240
- Alcon$216
- Bausch & Lomb, A Division Of Bausch Health US, LLC$131
- Kala Pharmaceuticals, Inc.$65
- AbbVie$53
- plus $137 from 6 others
What the payments were for
- Food & beverage$1,16098%
- Gifts$192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 8 | $338 |
| Tarsus Pharmaceuticals, Inc. | 10 | $240 |
| Alcon | 11 | $216 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $131 |
| Kala Pharmaceuticals, Inc. | 4 | $65 |
| AbbVie(2 entities) | 3 | $53 |
| Omeros Corporation | 2 | $38 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Oyster Point Pharma, Inc. | 1 | $15 |
| Harrow Eye, LLC | 1 | $14 |
| Maculogix, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,180 in reported general payments places this provider in the 65th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 61 | $2,097 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 41 | $1,318 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 16 | $707 |
| Prednisolone Acetate | 11 | $374 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Warsaw
- Roy KlineLake Katrine$822K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$374K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Justin BazanBrooklyn$303K
- Jennifer TsaiNew York$275K
- Alexander KabiriQueens Village$268K
- Sophia VisanjiNew York$233K
- Jason ComptonNew York$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.